Middle East Respiratory Syndrome

Cited by (516)

Items 101–200 of 516

1. Epidemiology, Virology, and Clinical Features of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2; Coronavirus Disease-19)
   Su Eun Park · 2020 · Pediatric Infection & Vaccine
2. Guide to Understanding the 2019 Novel Coronavirus
   Aditya Shah, Rahul Kashyap, Pritish K. Tosh, Priya Sampathkumar, John Charles O’Horo · 2020 · Mayo Clinic Proceedings
3. Protective efficacy of a novel simian adenovirus vaccine against lethal MERS-CoV challenge in a transgenic human DPP4 mouse model
   Vincent Jacobus Munster, Daniel Wells, Teresa Lambe, Daniel Wright, Robert J. Fischer, Trenton Bushmaker, Greg A. Saturday, Neeltje van Doremalen, Sarah C. Gilbert, Emmie de Wit et al. · 2017 · npj Vaccines
4. Managing Asthma during Coronavirus Disease-2019: An Example for Other Chronic Conditions in Children and Adolescents
   Elissa Michele Abrams, Stanley James Szefler · 2020 · The Journal of Pediatrics
5. The Pathology of Severe COVID-19-Related Lung Damage
   Felix K. F. Kommoss, Constantin Schwab, Luca Tavernar, Johannes Schreck, Willi Linus Wagner, Uta Merle, Danny David Jonigk, Peter Schirmacher, Thomas Longerich · 2020 · Deutsches Ärzteblatt international
6. Mucociliary Respiratory Epithelium Integrity in Molecular Defense and Susceptibility to Pulmonary Viral Infections
   Adivitiya, Manish Singh Kaushik, Soura Chakraborty, Shobi Veleri, Suneel Kateriya · 2021 · Biology
7. A child confirmed COVID-19 with only symptoms of conjunctivitis and eyelid dermatitis
   Ping Wu, Liang Liang, Jun Yang, ChunBao Chen, ShengQiong Nie · 2020 · Graefe s Archive for Clinical and Experimental Ophthalmology
8. Recent advances in SARS-CoV-2 Spike protein and RBD mutations comparison between new variants Alpha (B.1.1.7, United Kingdom), Beta (B.1.351, South Africa), Gamma (P.1, Brazil) and Delta (B.1.617.2, India)
   Paulo Ricardo da Silva Sanches, Ives Charlie‐Silva, Helyson Lucas Bezerra Braz, Cíntia Bittar, Marília Freitas Calmon, Paula Rahal, Eduardo Maffud Cilli · 2021 · Journal of Virus Eradication
9. Ocular surface manifestation of COVID-19 and tear film analysis
   Alessandro Meduri, Giovanni William Oliverio, Giuseppe Mancuso, Angela Giuffrida, Claudio Guarneri, Emmanuele Venanzi Rullo, Giuseppe Nunnari, Pasquale Aragona · 2020 · Scientific Reports
10. Repurposing of chloroquine and some clinically approved antiviral drugs as effective therapeutics to prevent cellular entry and replication of coronavirus
    Akinwunmi Oluwaseun Adeoye, Babatunde Joseph Oso, Ige Francis Olaoye, Habibu Tijjani, Ahmed I. Adebayo · 2020 · Journal of Biomolecular Structure and Dynamics
11. Could SARS‐CoV‐2 affect male fertility?
    Rahul Vishvkarma, Singh Rajender · 2020 · Andrologia
12. Middle East Respiratory Syndrome Coronavirus Infection Dynamics and Antibody Responses among Clinically Diverse Patients, Saudi Arabia
    Hail M. Al-Abdely, Claire M. Midgley, Abdulrahim M. Alkhamis, Glen R. Abedi, Xiaoyan Lu, Alison M. Binder, Khalid H. Alanazi, Azaibi Tamin, Weam M. Banjar, Sandra N. Lester et al. · 2019 · Emerging infectious diseases
13. MERS-CoV infection among healthcare workers and risk factors for death: Retrospective analysis of all laboratory-confirmed cases reported to WHO from 2012 to 2 June 2018
    Amgad Abdalla Elkholy, Rebecca Grant, Abdullah Mufareh Assiri, Mohamed Elhakim, Mamunur Rahman Malik, Maria D. Van Kerkhove · 2019 · Journal of Infection and Public Health
14. Risk Factors for Fatal Middle East Respiratory Syndrome Coronavirus Infections in Saudi Arabia: Analysis of the WHO Line List, 2013–2018
    Arifur Rahman, Atanu Sarkar · 2019 · American Journal of Public Health
15. Effects of Corticosteroid Treatment for Non-Severe COVID-19 Pneumonia: A Propensity Score-Based Analysis
    Mingli Yuan, Xiaoxiao Xu, Dongping Xia, Zhaowu Tao, Wen Yin, Weijun Tan, Yi Hu, Cheng Song · 2020 · Shock
16. ECMO use in COVID-19: lessons from past respiratory virus outbreaks—a narrative review
    Hwa Jin Cho, Silver Heinsar, In Seok Jeong, Kiran Shekar, Gianluigi Li Bassi, Jae Seung Jung, Jacky Yung Suen, John Francis Fraser · 2020 · Critical Care
17. Interferon Beta-1b and Lopinavir–Ritonavir for Middle East Respiratory Syndrome
    Yaseen M. Arabi, Ayed Y. Asiri, Abdullah Mufareh Assiri, Hanan H. Balkhy, Ali A. A. Al bshabshe, Majed Al Jeraisy, Yasser Mandourah, Mohamed H. Azzam, Abdulhadi M. Bin Eshaq, Sameera Al Johani et al. · 2020 · New England Journal of Medicine
18. COVID-19: an Immunopathological View
    Kamran Kadkhoda · 2020 · mSphere
19. COVID-19 Associated Invasive Pulmonary Aspergillosis: Diagnostic and Therapeutic Challenges
    Aia Mohamed, Thomas Richard Rogers, Alida Fe Talento · 2020 · Journal of Fungi
20. Mini-COVIDNet: Efficient Lightweight Deep Neural Network for Ultrasound Based Point-of-Care Detection of COVID-19
    Navchetan Awasthi, Aveen Dayal, Linga Reddy Cenkeramaddi, Phaneendra Kumar Yalavarthy · 2021 · IEEE Transactions on Ultrasonics Ferroelectrics and Frequency Control
21. Strategy and technology to prevent hospital-acquired infections: Lessons from SARS, Ebola, and MERS in Asia and West Africa
    Sanjeewa Jayachandra Rajakaruna, Wenbin Liu, Yibo Ding, Guangwen Cao · 2017 · Military Medical Research
22. Effectiveness and safety of glucocorticoids to treat COVID-19: a rapid review and meta-analysis
    on behalf of COVID-19 Evidence and Recommendations Working Group, Shuya Lu, Qi Xin Zhou, Liping Huang, Qianling Shi, Siya Zhao, Zijun Wang, Weiguo Li, Yuyi Tang, Yanfang Ma et al. · 2020 · Annals of Translational Medicine
23. COVID-19−Associated Encephalitis Mimicking Glial Tumor
    Ibrahim Efecan Efe, Orhun Utku Aydin, Alper Alabulut, Özgür İlhan Çelik, Kerameddin Aydın · 2020 · World Neurosurgery
24. Nonhuman Primate Models of Respiratory Disease: Past, Present, and Future
    Lisa A. Miller, Christopher M. Royer, Kent E. Pinkerton, Edward S. Schelegle · 2017 · ILAR Journal
25. Efficacy and safety of systematic corticosteroids among severe COVID-19 patients: a systematic review and meta-analysis of randomized controlled trials
    Shaolei Ma, Changsheng Xu, Shijiang Liu, Xiaodi Sun, Renqi Li, Mingjie Mao, Shanwu Feng, Xian Wang · 2021 · Signal Transduction and Targeted Therapy
26. COVID-19 pandemic: A review based on current evidence
    Bikash Medhi, VidyaM Mahalmani, Dhruv Mahendru, Ankita Semwal, Sukhmeet Kaur, Harpinder Kaur, Phulen Sarma, Ajay Prakash · 2020 · Indian Journal of Pharmacology
27. Rapid Antibody-Based COVID-19 Mass Surveillance: Relevance, Challenges, and Prospects in a Pandemic and Post-Pandemic World
    Robin Augustine, Suvarthi Das, Anwarul Hasan, Abhilash S, Shaheen Abdul Salam, Priya Augustine, Yogesh Bharat Dalvi, Ruby Varghese, Rosita Primavera, Hadi Mohamad Yassine et al. · 2020 · Journal of Clinical Medicine
28. Research Progress of Coronavirus Based on Bibliometric Analysis
    Fei Zhai, Yuxuan Zhai, Chuang Cong, Tingyan Song, Rongwu Xiang, Tianyi Feng, Zhengxuan Liang, Ya Zeng, Jing Yang, Jie Yang et al. · 2020 · International Journal of Environmental Research and Public Health
29. Neurological manifestations of COVID-19, SARS and MERS
    Kato Verstrepen, Laure Baisier, Harald De Cauwer · 2020 · Acta Neurologica Belgica
30. Targeting SARS-COV-2 non-structural protein 16: a virtual drug repurposing study
    Elham Tazikeh-Lemeski, Sajad Moradi, Rahim Raoufi, Mohsen Shahlaei, Mehr Ali Mahmood Janlou, Samaneh Zolghadri · 2020 · Journal of Biomolecular Structure and Dynamics
31. SARS‐CoV‐2 infection in children – Understanding the immune responses and controlling the pandemic
    Xiaoxia Lü, Yun Xiang, Hui Du, Gary Wong · 2020 · Pediatric Allergy and Immunology
32. Proteasome Inhibitors as a Possible Therapy for SARS-CoV-2
    Lucia Longhitano, Daniele Tibullo, Cesarina Giallongo, Giacomo Lazzarino, Nicola Tartaglia, Sara Galimberti, Giovanni Li Volti, Giuseppe A. Palumbo, Arcangelo Liso · 2020 · International Journal of Molecular Sciences
33. COVID-19 disease—Temporal analyses of complete blood count parameters over course of illness, and relationship to patient demographics and management outcomes in survivors and non-survivors: A longitudinal descriptive cohort study
    Simone Lanini, Chiara Montaldo, Emanuele Nicastri, Francesco Vairo, Chiara Agrati, Nicola Petrosillo, Paola Scognamiglio, Andrea Antinori, Vincenzo Puro, Antonino Di et al. · 2020 · PLoS ONE
34. Project IDentif.AI: Harnessing Artificial Intelligence to Rapidly Optimize Combination Therapy Development for Infectious Disease Intervention
    Aynur Abdulla, Boqian Wang, Qian Feng, Theodore Wonpeum Kee, Agata Blasiak, Yoong Hun Ong, Lissa Hooi, Falgunee K. Parekh, Rafael Soriano, Gene G. Olinger et al. · 2020 · Advanced Therapeutics
35. Neurological manifestations in COVID-19: A narrative review
    Asma Rahman, Roshan Niloofa, Ishan De Zoysa, Akila Cooray, Jayani Kariyawasam, Suranjith Luke Seneviratne · 2020 · SAGE Open Medicine
36. Clinical Characteristics, Diagnosis, and Treatment of Major Coronavirus Outbreaks
    Rupinder Mann, Abhilash Perisetti, Mahesh Gajendran, Zainab Gandhi, Chandraprakash Umapathy, Hemant Goyal · 2020 · Frontiers in Medicine
37. Molecular mechanisms and epidemiology of COVID-19 from an allergist’s perspective
    Hosoki, Koa, Chakraborty, Abhijit, Sur, Sanjiv · 2020 · Journal of Allergy and Clinical Immunology
38. Acute Kidney Injury in the 2019 Novel Coronavirus Disease
    Jing-Yi Qian, Bin Wang, Bi‐Cheng Liu · 2020 · Kidney Diseases
39. Recent biotechnological tools for diagnosis of corona virus disease: A review
    Bikash Chandra Behera, Rashmi R. Mishra, Hrudayanath Thatoi · 2020 · Biotechnology Progress
40. Adaptive evolution influences the infectious dose of MERS-CoV necessary to achieve severe respiratory disease
    Madeline G. Douglas, Jacob Kocher, Trevor Scobey, Ralph Steven Baric, Adam S. Cockrell · 2017 · Virology
41. MERS: Progress on the global response, remaining challenges and the way forward
    Ryan Aguanno, A.H. EL IDRISSI, Amgad Abdalla Elkholy, Peter Ben Embarek, Emma G. Gardner, Rebecca Grant, Heba Mahrous, Mamunur Rahman Malik, Gounalan Pavade, Sophie VonDobschuetz et al. · 2018 · Antiviral Research
42. Effect of interferon alpha and cyclosporine treatment separately and in combination on Middle East Respiratory Syndrome Coronavirus (MERS-CoV) replication in a human in-vitro and ex-vivo culture model
    Hung Sing Li, Denise I. T. Kuok, M.C. Cheung, Mandy M.T. Ng, Ka‐Chun Ng, Kenrie P. Y. Hui, Malik J. S. Peiris, Michael C. W. Chan, John Malcolm Nicholls · 2018 · Antiviral Research
43. Emergence of institutional antithrombotic protocols for coronavirus 2019
    Kevin P. Cohoon, Guillaume Mahé, Alfonso Javier Tafur, Alex C. Spyropoulos · 2020 · Research and Practice in Thrombosis and Haemostasis
44. High‐dose, short‐term corticosteroids for ARDS caused by COVID ‐19: a case series
    Clara So, Shosei Ro, Manabu Murakami, Ryosuke Imai, Torahiko Jinta · 2020 · Respirology Case Reports
45. A tricompartmental model of lung oxygenation disruption to explain pulmonary and systemic pathology in severe COVID-19
    Dennis McGonagle, Charlie Bridgewood, James F. Meaney · 2021 · The Lancet Respiratory Medicine
46. Descriptive study of COVID-19 outbreak among passengers and crew on Diamond Princess cruise ship, Yokohama Port, Japan, 20 January to 9 February 2020
    Takuya Yamagishi, Hajime Kamiya, Kensaku Kakimoto, Motoi Suzuki, Takaji Wakita · 2020 · Eurosurveillance
47. Consequences of COVID-19 for the Pancreas
    Urszula Abramczyk, Maciej Nowaczyński, Adam Słomczyński, Piotr Wojnicz, Piotr Zatyka, Aleksandra Kuzan · 2022 · International Journal of Molecular Sciences
48. Comparative Analysis of Eleven Healthcare-Associated Outbreaks of Middle East Respiratory Syndrome Coronavirus (Mers-Cov) from 2015 to 2017
    Sibylle Bernard-Stoecklin, Birgit Nikolay, Abdullah Mufareh Assiri, Abdulaziz Bin Saeed, Peter Karim Ben Embarek, Hassan E El Bushra, Moran Ki, Mamunur Rahman Malik, Arnaud L Fontanet, Simon Cauchemez et al. · 2019 · Scientific Reports
49. Anosmia: a missing link in the neuroimmunology of coronavirus disease 2019 (COVID-19)
    Niloufar Yazdanpanah, Amene Saghazadeh, Nima Rezaei · 2020 · Reviews in the Neurosciences
50. The Rise of SARS-CoV-2 Variants and the Role of Convalescent Plasma Therapy for Management of Infections
    Mohamed Moubarak, Keneth Iceland Kasozi, ‏Helal F. Hetta, Hazem Mohammed Shaheen, Abdur Rauf, Hayder Mutter Al-Kuraishy, Safaa Y. Qusti, Eida Mohammed Alshammari, Emmanuel Tiyo Ayikobua, Fred Ssempijja et al. · 2021 · Life
51. Sudden Sensorineural Hearing Loss in Mild COVID-19: Case Series and Analysis of the Literature
    Filippo Ricciardiello, Davide Pisani, Pasquale Viola, Elisabetta Cristiano, Alfonso Scarpa, Antonio Giannone, Giuseppe Longo, Giuseppe Russo, Marco Bocchetti, Ciro Coppola et al. · 2021 · Audiology Research
52. Middle East Respiratory Syndrome Coronavirus (MERS-CoV): State of the Science
    Ahmed Mostafa, Ahmed Kandeil, Mahmoud Shehata, Rabeh El‐Shesheny, Abdallah M Samy, Ghazi Kayali, Mohamed A. Ali · 2020 · Microorganisms
53. The atherogenic index of plasma as a predictor of mortality in patients with COVID-19
    Özge Turgay Yıldırım, Şeyhmus Kaya · 2021 · Heart & Lung
54. Increased complications of COVID-19 in people with cardiovascular disease: Role of the renin–angiotensin-aldosterone system (RAAS) dysregulation
    Robin Augustine, Abhilash S, Ajisha Nayeem, Shaheen Abdul Salam, Priya Augustine, Pan Dan, Pablo Maureira, Fatima Mraiche, Carmine Gentile, Philip M. Hansbro et al. · 2021 · Chemico-Biological Interactions
55. Viral arthralgia a new manifestation of COVID-19 infection? A cohort study of COVID-19-associated musculoskeletal symptoms
    Caroline Wei Shan Hoong, Muhammad Amin, Teck Choon Tan, Jer En Lee · 2021 · International Journal of Infectious Diseases
56. Depletion and Dysfunction of Dendritic Cells: Understanding SARS-CoV-2 Infection
    Teding Chang, Jingzhi Yang, Hai Deng, Deng Chen, Xiang‐Ping Yang, Zhaohui Tang · 2022 · Frontiers in Immunology
57. First case of focal epilepsy associated with SARS‐coronavirus‐2
    Sara Elgamasy, Mohamed Gomaa Kamel, Sherief A. Ghozy, Adham M. Khalil, Mostafa Ebraheem Morra, Sheikh Mohammed Shariful Islam · 2020 · Journal of Medical Virology
58. Novel insights into the treatment of SARS-CoV-2 infection: An overview of current clinical trials
    Fatemeh Oroojalian, Ali Haghbin, Behzad Baradaran, Nima Hemmat, Mohammad‐Ali Shahbazi, Hossein Bannazadeh Baghi, Ahad Mokhtarzadeh, Michael Richard Hamblin · 2020 · International Journal of Biological Macromolecules
59. Acute inflammation and pathogenesis of SARS-CoV-2 infection: Cannabidiol as a potential anti-inflammatory treatment?
    Cecilia Theresa Costiniuk, Mohammad-Ali Jenabian · 2020 · Cytokine & Growth Factor Reviews
60. Immune Alterations in a Patient with SARS-CoV-2-Related Acute Respiratory Distress Syndrome
    Lila Bouadma, Aurélie Wiedemann, Juliette Patrier, Mathieu Surénaud, Paul-Henri Wicky, Emile Foucat, Jean‐Luc Diehl, Boris P. Hejblum, Fabrice Sinnah, Étienne de Montmollin et al. · 2020 · Journal of Clinical Immunology
61. Electroencephalographic (EEG) features of encephalopathy in the setting of Covid-19: A case series
    Luke Canham, Lydia E. Staniaszek, Alex Mark Mortimer, L.F. Nouri, Nicholas Kane · 2020 · Clinical Neurophysiology Practice
62. Acute Kidney Injury Is Associated With In-hospital Mortality in Older Patients With COVID-19
    Qi Yan, Peiyuan Zuo, Ling Jie Cheng, Yuanyuan Li, Kaixin Song, Yuting Chen, Yue Dai, Yi Yang, Lun Zhou, Weiwei Yu et al. · 2020 · The Journals of Gerontology Series A
63. Neurological Damage by Coronaviruses: A Catastrophe in the Queue!
    Ritu Mishra, Akhil Chandra Banerjea · 2020 · Frontiers in Immunology
64. An Overview of Vaccines against SARS-CoV-2 in the COVID-19 Pandemic Era
    Alejandro Pascual‐Iglesias, Javier Cantón, Ana Maria Ortega‐Prieto, Jose M. Jiménez-Guardeño, José Ángel Regla-Nava · 2021 · Pathogens
65. Inactivation of Middle East respiratory syndrome‐coronavirus in human plasma using amotosalen and ultraviolet A light
    Salwa Hindawi, Anwar M. Hashem, Ghazi A. Damanhouri, Sherif Aly El-Kafrawy, Ahmed M. Tolah, Ahmed M. Hassan, Esam I. Azhar · 2017 · Transfusion
66. Managing Oncology Services During a Major Coronavirus Outbreak: Lessons From the Saudi Arabia Experience
    Abdul Rahman Jazieh, Abdulrahman Al Hadab, Ashwaq Al Olayan, Ayman Alhejazi, Faisal Al Safi, Abullah Al Qarni, Faisal Farooqui, Nashmia Al Mutairi, Thamer H. Alenazi · 2020 · JCO Global Oncology
67. Basal Ganglia Involvement and Altered Mental Status: A Unique Neurological Manifestation of Coronavirus Disease 2019
    Kaveh Haddadi, Roya Ghasemian, Misagh Shafizad · 2020 · Cureus
68. On the Coronaviruses and Their Associations with the Aquatic Environment and Wastewater
    Adrian Wartecki, Piotr Rzymski · 2020 · Water
69. Bushmeat, wet markets, and the risks of pandemics: Exploring the nexus through systematic review of scientific disclosures
    Colin Scott Peros, Rajarshi Dasgupta, Pankaj Kumar, Brian Alan Johnson · 2021 · Environmental Science & Policy
70. Reducing mortality and morbidity in patients with severe COVID-19 disease by advancing ongoing trials of Mesenchymal Stromal (stem) Cell (MSC) therapy — Achieving global consensus and visibility for cellular host-directed therapies
    Alimuddin I. Zumla, Fu‐Sheng Wang, Giuseppe Ippolito, Nicola Petrosillo, Chiara Agrati, Esam I. Azhar, Chao Chien Chang, Sherif Aly El-Kafrawy, Mohamed Osman, Laurence Zitvogel et al. · 2020 · International Journal of Infectious Diseases
71. Secondary infections in critically ill patients with COVID-19
    Giacomo Grasselli, Emanuele Cattaneo, Gaetano Florio · 2021 · Critical Care
72. Exogenous Coronavirus Interacts With Endogenous Retrotransposon in Human Cells
    Ying Yin, Xiaozhao Liu, Ximiao He, Liquan Zhou · 2021 · Frontiers in Cellular and Infection Microbiology
73. Clinical characteristics and corticosteroids application of different clinical types in patients with corona virus disease 2019
    Fangfang Liu, Chengcheng Ji, Jiajun Luo, Weiwei Wu, Junchang Zhang, Zhiqiang Zhong, Seth Lankford, Huang Huang, Fang Lin, Yonggang Wang et al. · 2020 · Scientific Reports
74. Non-human primate models of human respiratory infections
    Julien Lemaître, Thibaut Naninck, B. Delache, J. Creppy, P. Huber, Marion Holzapfel, Camille Bouillier, V. Contreras, F. Martinon, Nidhal Kahlaoui et al. · 2021 · Molecular Immunology
75. A blood-based host gene expression assay for early detection of respiratory viral infection: an index-cluster prospective cohort study
    Micah T. McClain, Florica J. Constantine, Bradly P. Nicholson, Marshall Nichols, Thomas W. Burke, Ricardo Henao, Daphne C Jones, Lori L. Hudson, L. Brett Jaggers, Timothy Veldman et al. · 2020 · The Lancet Infectious Diseases
76. Human Coronavirus Infections—Severe Acute Respiratory Syndrome (SARS), Middle East Respiratory Syndrome (MERS), and SARS-CoV-2
    David S.C. Hui, Esam I. Azhar, Ziad Ahmed Memish, Alimuddin I. Zumla · 2020 · Elsevier eBooks
77. Outcomes of Renal Transplant Recipients With SARS-CoV-2 Infection in the Eye of the Storm: A Comparative Study With Waitlisted Patients
    Ismail Mohamed, Prashanth Basappa Chowdary, Shraddha Shetty, Cinzia Sammartino, Rajesh Sivaprakasam, Ben Lindsey, Raj C. Thuraisingham, Muhammad Magdi Yaqoob, Muhammad Arslan Khurram · 2020 · Transplantation
78. Antiviral Activity of Umifenovir In Vitro against a Broad Spectrum of Coronaviruses, Including the Novel SARS-CoV-2 Virus
    Ирина Анатольевна Ленева, Карташова Надежда Павловна, А. А. Поромов, Anastasiia V. Gracheva, E. R. Korchevaya, Глубокова Екатерина Андреевна, Olga V. Borisova, Штро Анна Андреевна, S. Ya. Loginova, Щукина Вероника Николаевна et al. · 2021 · Viruses
79. The Clinical Manifestations and Chest Computed Tomography Findings of Coronavirus Disease 2019 (COVID-19) Patients in China: A Proportion Meta-Analysis
    Joo Hyun Park, Wook Jang, Sang Woo Kim, Jeongjun Lee, Yun‐Sung Lim, Chang Gun Cho, Seok‐Won Park, Bo Hae Kim · 2020 · Clinical and Experimental Otorhinolaryngology
80. MERS-CoV: epidemiology, molecular dynamics, therapeutics, and future challenges
    Ali Ahmed Rabaan, Shamsah H. Al-Ahmed, Ranjit Sah, Mohammed A. A. Alqumber, Shafiul Haque, Shailesh Kumar Patel, Mamta Pathak, Ruchi Tiwari, Mohd. Iqbal Yatoo, Abrar Ul Haq et al. · 2021 · Annals of Clinical Microbiology and Antimicrobials
81. The history and epidemiology of Middle East respiratory syndrome corona virus
    Aisha M. Al-Osail, Marwan Jabr Alwazzeh · 2017 · Multidisciplinary Respiratory Medicine
82. Exploring the clinical association between neurological symptoms and COVID-19 pandemic outbreak: a systematic review of current literature
    Davide Tiziano Di Carlo, Nicola Montemurro, Giandomenico Petrella, Gabriele Siciliano, Roberto Ceravolo, Paolo Perrini · 2020 · Journal of Neurology
83. Evolution of the SARS-CoV-2 genome and emergence of variants of concern
    Iman Safari, Elahe Elahi · 2021 · Archives of Virology
84. Involvement of Matrix Metalloproteinases in COVID-19: Molecular Targets, Mechanisms, and Insights for Therapeutic Interventions
    Rebecca Salomão, Victória Assis, Ivo Vieira de Sousa Neto, Bernardo Assis Petriz, Nicolas Babault, João Luíz Quagliotti Durigan, Rita de Cássia Marqueti · 2023 · Biology
85. Report of the National Institutes of Health SARS-CoV-2 Antiviral Therapeutics Summit
    Matthew D. Hall, James Melvin Anderson, Annaliesa S. Anderson, David A. Baker, James E. Bradner, Kyle R. Brimacombe, Elizabeth A. Campbell, Kizzmekia S. Corbett, Kara L. Carter, Sara R. Cherry et al. · 2021 · The Journal of Infectious Diseases
86. Description of symptom course in a telemedicine monitoring clinic for acute symptomatic COVID-19: a retrospective cohort study
    James B. O’Keefe, Elizabeth J. Tong, Ghazala A. Datoo O’Keefe, David C. Tong · 2021 · BMJ Open
87. Cuidados intensivos durante la epidemia de coronavirus 2019
    Alejandro González-Castro, P. Escudero-Acha, Yhivian Peñasco, Oihana Leizaola, V. Martínez de Pinillos Sánchez, A. García de Lorenzo · 2020 · Medicina Intensiva
88. Immuno-epidemiology and pathophysiology of coronavirus disease 2019 (COVID-19)
    Omalla Allan Olwenyi, Shetty Ravi Dyavar, Arpan Acharya, Anthony T. Podany, Courtney Vail Fletcher, Caroline L. Ng, St Patrick Reid, Siddappa N. Byrareddy · 2020 · Journal of Molecular Medicine
89. Are environmental pollution and biodiversity levels associated to the spread and mortality of COVID-19? A four-month global analysis
    Daniel Fernández, Iago Giné-Vázquez, Ivy Liu, Recai Murat Yucel, Marta Nai Ruscone, Marianthi Morena, V.G. García, Josep Maria Haro, William Pan, Stefanos Tyrovolas · 2020 · Environmental Pollution
90. When silence goes viral, Africa sneezes! A perspective on Africa's subdued research response to COVID-19 and a call for local scientific evidence
    Willis Gwenzi, Piotr Rzymski · 2020 · Environmental Research
91. New and emerging infectious diseases (Ebola, Middle Eastern respiratory syndrome coronavirus, carbapenem-resistant Enterobacteriaceae, Candida auris): Focus on environmental survival and germicide susceptibility
    David Jay Weber, Emily E. Sickbert-Bennett, Hajime Kanamori, William A. Rutala · 2019 · American Journal of Infection Control
92. Use of Enoxaparin to Counteract COVID-19 Infection and Reduce Thromboembolic Venous Complications: A Review of the Current Evidence
    Filippo Drago, Lucia Gozzo, Li Li, Andréa Stella, Benilde Cosmi · 2020 · Frontiers in Pharmacology
93. SARS-CoV-2 Spike Alterations Enhance Pseudoparticle Titers and Replication-Competent VSV-SARS-CoV-2 Virus
    Katherine E. Havranek, Ariana R. Jimenez, Marissa Danielle Acciani, Maria Lay Mendoza, Judith Mary Reyes Ballista, Darren Diaz, Melinda Ann Brindley · 2020 · Viruses
94. Natural and Nature-Derived Products Targeting Human Coronaviruses
    Konstantina Vougogiannopoulou, Angela Corona, Enzo Tramontano, Μichael N. Alexis, Alexios‐Léandros Skaltsounis · 2021 · Molecules
95. Clinical and Laboratory Findings of Middle East Respiratory Syndrome Coronavirus Infection
    Se-Min Hwang, Baeg-Ju Na, Yoomi Jung, Hyun-Suk Lim, Jeong-Eun Seo, Shin-Ae Park, Young-Soo Cho, Eun-Hyang Song, Ji-Yeon Seo, Sung‐Ryul Kim et al. · 2018 · Japanese Journal of Infectious Diseases
96. Molecular characterization, pathogen-host interaction pathway and in silico approaches for vaccine design against COVID-19
    Nidhi Singh, Sachchida Nand, Veer Singh, Mohan Prasad Singh · 2020 · Journal of Chemical Neuroanatomy
97. Unfolded Protein Response Inhibition Reduces Middle East Respiratory Syndrome Coronavirus-Induced Acute Lung Injury
    Amy María Sims, Hugh D. Mitchell, Lisa E. Gralinski, Jennifer E Kyle, Kristin Burnum-Johnson, Mariam Lam, M. Leslie Fulcher, Ande West, Richard D. Smith, Scott H. Randell et al. · 2021 · mBio
98. Amotosalen and ultraviolet A light efficiently inactivate MERS‐coronavirus in human platelet concentrates
    Anwar M. Hashem, Ahmed M. Hassan, Ahmed M. Tolah, Mohammed Alsaadi, Q. Abunada, Ghazi A. Damanhouri, Sherif Aly El-Kafrawy, Marcus Picard‐Maureau, Esam I. Azhar, Salwa Hindawi · 2019 · Transfusion Medicine
99. Current understanding of middle east respiratory syndrome coronavirus infection in human and animal models
    Yanqun Wang, Jing Sun, Airu Zhu, Jingxian Zhao, Jincun Zhao · 2018 · Journal of Thoracic Disease
100. Cyclophilin inhibitors restrict Middle East respiratory syndrome coronavirusviainterferon-λin vitroand in mice
     Lucie Sauerhering, Alexandra Kupke, Lars Meier, Erik Dietzel, Judith Hoppe, Achim Dieter Gruber, Stefan Gattenloehner, Biruta Witte, Ludger Fink, Nina Hofmann et al. · 2020 · European Respiratory Journal